Related Experiment Video
Updated: Jul 19, 2026

Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
[Lipometabolic disorder--cholesterol and triglycerides]
1Otto-von-Guericke-Universität Magdeburg, Institut für Klinische Chemie und Pathobiochemie, Leipziger Str. 44, 39120 Magdeburg, Germany.
Insights
Cholesterol resorption inhibitors combined with statins effectively lower LDL by 50-60%. Triglyceride management is crucial for cardiovascular risk, especially in diabetes and obesity.
Area of Science:
- Cardiology
- Pharmacology
Context:
- Hypercholesterolemia management often involves combination therapy with statins and cholesterol absorption inhibitors.
- Elevated LDL cholesterol poses a significant cardiovascular risk, necessitating target values like 100 mg/dl for high-risk patients.
Purpose:
- To outline current therapeutic strategies for managing hypercholesterolemia and dyslipidemia.
- To emphasize the importance of triglyceride levels in assessing cardiovascular risk, particularly in the context of obesity and diabetes.
Summary:
- Combination therapy with statins and cholesterol absorption inhibitors can reduce LDL cholesterol by 50-60%.
- Triglyceride levels >200 mg/dl require lifestyle modifications and potentially medications like fibrates, omega-3 fatty acids, or nicotinic acid.
- Severe hypertriglyceridemia (>1000 mg/dl) necessitates immediate medical intervention.
Impact:
- Provides a concise overview of lipid-lowering strategies for clinicians and patients.
- Highlights the dual importance of LDL and triglyceride management in reducing overall cardiovascular risk.
Abstract:
Resorption inhibitors for cholesterol are commonly applied today in case of hypercholesterolemia in addition to statins. This combination therapy reduces the value of the LDL concentration by 50-60%. A target value of 100 mg/dl should be adjusted in case of high-risk patients in order to also decrease coronary risk. The significance of the triglycerides level is also becoming increasingly important, for it describes a high cardiovascular risk due to an increase of adiposity and diabetes. Such a dysfunction in storage and release of fatty lipids from triglycerides is treated dependent on severity: Patients with slightly elevated values (> 200 mg/dl) should change their habits (e.g. balanced diet, abstinance of alcohol, exercise) if necessary followed by application of fibrates, omega-3 fatty acids or nicotinic acid. These medicamentous measures are inevitable and must be applied immediately in case patients having values >1000 mg/dl.
Related Concept Videos
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipid Catabolism
Lipid Absorption
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...